CRSP · CRISPR Therapeutics AG · Debt
$49.39
-0.60 (-1.20%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$4.78B
Shares
96.69M
Volume · Oct 23
2.12M
Avg daily vol (3M)
1.56M
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 18,646,000 | 10-Q filed 2026-08-03 |
| Long-term debt, including current maturities | 2026-06-30 | USD 586,198,000 | 10-Q filed 2026-08-03 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 178,904,000 | 10-Q filed 2026-08-03 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Key facts
CIK
1674416
CUSIP
H17182108
13F (30d)
89 filings
89 filers
Visit website
Investor relations